Cargando…

Evaluation of real-world mobility in age-related macular degeneration

BACKGROUND: Previous research has suggested an association between poor vision and decreased mobility, including restricted levels of physical activity and travel away from home. We sought to determine the impact of age-related macular degeneration (AMD) on these measures of mobility. METHODS: Fifty...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sengupta, Sabyasachi, Nguyen, Angeline M, van Landingham, Suzanne W, Solomon, Sharon D, Do, Diana V, Ferrucci, Luigi, Friedman, David S, Ramulu, Pradeep Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328075/ https://www.ncbi.nlm.nih.gov/pubmed/25636376 http://dx.doi.org/10.1186/1471-2415-15-9

Ejemplares similares

Fear of falling in age-related macular degeneration
por: van Landingham, Suzanne W, et al.
Publicado: (2014)

Gait Characteristics of Age-Related Macular Degeneration Patients
por: Varadaraj, Varshini, et al.
Publicado: (2017)

Physical Activity in Functionally Monocular Persons in the United States, 2003–2006
por: Papudesu, Chandana, et al.
Publicado: (2023)

Driving patterns in older adults with glaucoma
por: van Landingham, Suzanne W, et al.
Publicado: (2013)

Real‐world treatment outcomes of neovascular Age‐related Macular Degeneration in the Netherlands
por: Verbraak, Frank D., et al.
Publicado: (2020)

Age-Related Macular Degeneration Is Associated with Less Physical Activity among US Adults: Cross-Sectional Study
por: Loprinzi, Paul D., et al.
Publicado: (2015)

Real-World Injection Frequency and Cost of Ranibizumab and Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
por: Kiss, Szilárd, et al.
Publicado: (2020)

Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan
por: Chang, Yi-Sheng, et al.
Publicado: (2018)

Publish or perish: The art of scientific writing
por: Sengupta, Sabyasachi, et al.
Publicado: (2014)

Physical activity restriction in age-related eye disease: a cross-sectional study exploring fear of falling as a potential mediator
por: Nguyen, Angeline M., et al.
Publicado: (2015)

Real-World Experience with Brolucizumab in Wet Age-Related Macular Degeneration: The REBA Study
por: Bilgic, Alper, et al.
Publicado: (2021)

Consequences of Real-World Surveillance of Fellow Eyes in Neovascular Age-Related Macular Degeneration
por: Onwuka, Oluchukwu, et al.
Publicado: (2023)

Treatment of neovascular age-related macular degeneration: insights into drug-switch real-world from the Berlin Macular Registry
por: Riemer, Tommes, et al.
Publicado: (2023)

Neovascular age‐related macular degeneration: A review of findings from the real‐world Fight Retinal Blindness! registry
por: Nguyen, Vuong, et al.
Publicado: (2021)

Brolucizumab in Neovascular Age-Related Macular Degeneration – Indian Real-World Experience: The BRAILLE Study
por: Chakraborty, Debdulal, et al.
Publicado: (2021)

Initial Real-World Experience with Faricimab in Treatment-Resistant Neovascular Age-Related Macular Degeneration
por: Leung, Ella H, et al.
Publicado: (2023)

Treatment patterns in patients with age-related macular degeneration and diabetic macular edema: A real-world claims analysis in Dubai
por: Kozak, Igor, et al.
Publicado: (2021)

Correction to: Treatment of neovascular age-related macular degeneration: insights into drug-switch real-world from the Berlin Macular Registry
por: Riemer, Tommes, et al.
Publicado: (2023)

Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence
por: Daien, Vincent, et al.
Publicado: (2021)

Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies
por: Carrasco, Joao, et al.
Publicado: (2019)

The Association of Glaucomatous Visual Field Loss and Balance
por: de Luna, Regina A., et al.
Publicado: (2017)

Real-world study to evaluate the efficacy and safety of intravitreal brolucizumab for refractory neovascular age-related macular degeneration
por: Yeom, Hoseok, et al.
Publicado: (2023)

Gait in Elderly Glaucoma: Impact of Lighting Conditions, Changes in Lighting, and Fear of Falling
por: Bicket, Amanda K., et al.
Publicado: (2020)

Age-related macular degeneration and resource utilization in the Brazilian public healthcare system: a real-world retrospective study
por: Touma-Falci, Liane, et al.
Publicado: (2021)

Eligibility for faricimab in a real-world neovascular age-related macular degeneration population: a cross-sectional study
por: Jern, Iréne, et al.
Publicado: (2022)

Real-World Experience Using Intravitreal Brolucizumab Alone or in Combination with Aflibercept in the Management of Neovascular Age-Related Macular Degeneration
por: Mehta, Neesurg, et al.
Publicado: (2023)

Real-World Frequency and Management of Ocular Adverse Events in Eyes with Neovascular Age-Related Macular Degeneration Treated with Brolucizumab
por: Zubricky, Ryan, et al.
Publicado: (2023)

The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results
por: Khanani, Arshad M., et al.
Publicado: (2023)

Evaluation of markers of outcome in real-world treatment of diabetic macular edema
por: Campos, António, et al.
Publicado: (2018)

Real-Life Data of Patients with Exudative Age-Related Macular Degeneration
por: Togac, Mesut, et al.
Publicado: (2021)

How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review
por: Taylor, Deanna J, et al.
Publicado: (2016)

Biomarkers of optical coherence tomography in evaluating the treatment outcomes of neovascular age-related macular degeneration: a real-world study
por: Lai, Tso-Ting, et al.
Publicado: (2019)

Twenty-four-month real-world visual outcomes of intravitreal aflibercept as monotherapy for the treatment of neovascular age-related macular degeneration
por: Siempis, Thomas, et al.
Publicado: (2019)

Real-World Performance of a Self-Operated Home Monitoring System for Early Detection of Neovascular Age-Related Macular Degeneration
por: Ho, Allen C., et al.
Publicado: (2021)

Real-World Outcomes of Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration: A Large-Scale Postmarketing Surveillance in Korea
por: Ryu, Gahyung, et al.
Publicado: (2021)

Ten-Year Real-World Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration
por: Cheema, Muhammad Raza, et al.
Publicado: (2021)

Treatment Outcome of Wet Age-Related Macular Degeneration Management in Thailand: A Retrospective Real-World Study (TOWER Study)
por: Thoongsuwan, Somanus, et al.
Publicado: (2022)

Brolucizumab in Neovascular Age-Related Macular Degeneration – Indian Real-World Experience: The BRAILLE Study – Fifty-Two-Week Outcomes
por: Chakraborty, Debdulal, et al.
Publicado: (2022)

Long-term surveillance provides real-world evidences of safety and effectiveness in intravitreal aflibercept treatment for age-related macular degeneration
por: Ozawa, Yoko, et al.
Publicado: (2023)

Discontinuation of treatment and retreatment of neovascular age-related macular degeneration in the real-world: Bundang AMD cohort study report 5
por: Cho, Soo Chang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_splmf1h1etmmq0ptd1c94o7r3j